Vilor FG 200 mcg DPI 15's

Vilor FG 200 mcg DPI 15's

Prescription drug
Manufacturer / Marketer : ETABX
Expiry : 29-02-2028
AboutVilor FG 200 mcg DPI is a combination dry powder inhaler containing fluticasone furoate (100 mcg) and vilanterol (25 mcg), used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) in adults. It combines an inhaled corticosteroid and long-acting beta-agonist (LABA) for comprehensive airway control.Usage InstructionsInhale one dose once daily as prescribed by your doctor. Do not exceed prescribed dose. Rinse mouth with water after each use to prevent oral thrush. This is a maintenance inhaler, not for acute asthma or COPD attacks. Use regularly for best results.Benefits- Prevents asthma attacks and COPD symptoms- Once-daily dosing convenience- Reduces airway inflammation (fluticasone)- Long-acting bronchodilation for 24 hours (vilanterol)- Improves lung function and breathing- Reduces need for rescue inhalersHow it WorksFluticasone furoate (inhaled corticosteroid) reduces airway inflammation; vilanterol (ultra-long-acting beta-agonist) relaxes airway smooth muscles for 24-hour bronchodilation, providing comprehensive asthma and COPD control.Side EffectsCommon: Throat irritation, hoarseness, oral thrush, headache, nasopharyngitis, cough. Less common: Increased heart rate, tremor, palpitations, pneumonia (in COPD patients). Rare: Paradoxical bronchospasm, adrenal suppression with high doses, QT prolongation.Safety Advice- Prescription required - use only as directed- Not for acute asthma or COPD attacks (use rescue inhaler)- Rinse mouth after each use to prevent thrush- Do not stop suddenly; may worsen asthma/COPD- Inform doctor of heart disease, diabetes, thyroid problems, seizures- Monitor for worsening breathing or pneumonia symptoms (COPD patients)- Regular check-ups for long-term use- May increase risk of pneumonia in COPD patientsStorageStore below 30°C in a dry place. Protect from moisture and direct sunlight. Do not puncture or expose to heat. Keep inhaler dry and in original packaging. Discard 6 weeks after opening or when dose counter shows 0.
₹712.50 MRP: ₹750.00 Save ₹37.50 (5%)
Inclusive of all taxes
Quantity

Expiry Icon
Fresh Stock
Guaranteed
Return Icon
Secure & Hygienic
Packaging
Authentic Icon
Verified & Trusted
Supplements
Quality Icon
Secure
Payment
AboutVilor FG 200 mcg DPI is a combination dry powder inhaler containing fluticasone furoate (100 mcg) and vilanterol (25 mcg), used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) in adults. It combines an inhaled corticosteroid and long-acting beta-agonist (LABA) for comprehensive airway control.Usage InstructionsInhale one dose once daily as prescribed by your doctor. Do not exceed prescribed dose. Rinse mouth with water after each use to prevent oral thrush. This is a maintenance inhaler, not for acute asthma or COPD attacks. Use regularly for best results.Benefits- Prevents asthma attacks and COPD symptoms- Once-daily dosing convenience- Reduces airway inflammation (fluticasone)- Long-acting bronchodilation for 24 hours (vilanterol)- Improves lung function and breathing- Reduces need for rescue inhalersHow it WorksFluticasone furoate (inhaled corticosteroid) reduces airway inflammation; vilanterol (ultra-long-acting beta-agonist) relaxes airway smooth muscles for 24-hour bronchodilation, providing comprehensive asthma and COPD control.Side EffectsCommon: Throat irritation, hoarseness, oral thrush, headache, nasopharyngitis, cough. Less common: Increased heart rate, tremor, palpitations, pneumonia (in COPD patients). Rare: Paradoxical bronchospasm, adrenal suppression with high doses, QT prolongation.Safety Advice- Prescription required - use only as directed- Not for acute asthma or COPD attacks (use rescue inhaler)- Rinse mouth after each use to prevent thrush- Do not stop suddenly; may worsen asthma/COPD- Inform doctor of heart disease, diabetes, thyroid problems, seizures- Monitor for worsening breathing or pneumonia symptoms (COPD patients)- Regular check-ups for long-term use- May increase risk of pneumonia in COPD patientsStorageStore below 30°C in a dry place. Protect from moisture and direct sunlight. Do not puncture or expose to heat. Keep inhaler dry and in original packaging. Discard 6 weeks after opening or when dose counter shows 0.

Related Products